Skip to main content
. 2018 Oct 8;6:260. doi: 10.3389/fped.2018.00260

Table 1.

Characteristics of descriptive studies about antibiotic prescription.

Reference, Country Study design Age group/inclusion Median (IQR) or Mean age ± SD Inclusion criteria N children included Quality
Ahmed et al. (19), US CSp 0–18 years NR URTI 321 Low
Angoulvant et al. (20), France CR <18 years 17 months (7–40) ARTI 53.055 High
Aronson et al. (21), US CSr 29–56 days 46 days (37–53) Fever 1626 High
45 days (37–53)
Ayanruoh et al. (22), US CSr 3–18 years NR Clinical diagnosis of pharyngitis 8280 Low
Benin et al. (23), US CSr 3–18 years 8.7 years (6–13) Diagnosis pharyngitis 391 Moderate
Benito-Fernández et al. (24), Spain CP 0–36 months 6.86 months ± 6.3° Fever without source 206 Low
6.55 months ± 6.8°
Blaschke et al. (25) US CSr All ages 53% < 18 years Influenza 58 Low
Brauner et al. (26), Israel CCr 3–36 months NR Fever and complete blood count 292 Moderate
Bonner et al. (27), US RCT 2 months−21 years NR Influenza 202 Moderate
Bustinduy et al. (28), UK CP <16 years 2 years (1–4 years) Fever or reported fever 1097 Moderate
Chao et al. (29), US RCT 2–12 years 5.01 years (3.67–6.68) AOM 206 Moderate
3.73 years (2.82–5.75)
Craig et al. (3), Australia CP <6 years ± 60% < 24 months Fever 15.781 High
Coco et al. (30), US CSr <12 years ± 2 years* AOM 8325 High
Colvin et al. (31), US CP 2–36 months 8.0 months Fever without source ¥ 75 Low
Copp et al. (32), US CSr <18 years ±6 years* UTI 1828 (36% in ED) Low
Doan et al. (33), Canada RCT 3–36 months 15 months (3–36) Acue respiratory symptoms 199 Moderate
14 months (4–34)
Fischer et al. (34), US CP 2–18 years 68% 2–6 years AOM 144 Low
Galetto Lacour et al. (35), Switzerland CP 7 days −36 months 11 months* Fever without source ¥ 124 Moderate
Galetto-Lacour et al. (35), Switzerland CP 7 days −36 months 7.2 months (0.4–31.1) Fever without source ¥ 99 Low
9.7 months (0.7–34)
Goldman et al. (36), Canada CP <3 months 48.7 days ± 23.6° Fever 257 Low
Houten et al. (37), Netherlands CP 2–60 months 21 months ± 16° Fever and LRTI symptoms or without source 577 Moderate
Irwin et al. (38), UK CP <16 years 2.4 years (0.9–5.7) Fever and blood tests 1101 High
Isaacman et al. (39), US CR 3–36 months 18 months ± 9.8° Fever without source in a GED¥ 79 Low
16.3 months ±8.8° Fever without source in a PED¥ 498
Iyer et al. (40), US RCT 2–24 months ±75% 6–24 months Fever 700 Moderate
Jain et al. (41), US CP <18 years NR Fever 19075 High
Khine et al. (42), US CR 3–36 months 15.2 months ±8.7° Reported fever in GED 237 Moderate
3–36 months 16.6 months ±9.1° Reported fever in PED 224
Kilic et al. (43) Turkey CSr 3–140 months 41.2 months ±31° Asthma, croup, Bronchiolitis 2544 Low
Kornblith et al. (44), US CSr 0–18 years ± 56% 1–5 years ARTI 6461 High
Kronman et al. (45), US CSr 1–18 years 50–60% 1–5 years CAP 266.000 High
Lacroix et al. (46), France RCT 7 days−36 months 3.4 months (1.5–10.4) Fever without source 271 High
4.8 months (1.7–10.4)
Linder et al. (47), US CSr 3–17 years 45% 6–11 years Sore throat 6955 High
Li-Kim-Moy et al. (48), Australia CR 0 ≤ 18 years 3.1 years (1.1–7.4) Lab proven influenza 301 Moderate
Manzano et al. (49), Canada RCT 1–36 months 12 ± 8 months° Fever 384 High
12 ± 8 months°
Massin et al. (50) Belgium CP 1–36 months 13.8 months ±9.7° Fever without source ¥ 376 Moderate
McCaig et al. (51), US CSr 3 months−2 years NR Fever and BC (discharged) 5.4% of all ED visits Low
McCormick et al. (52), US RCT 6–72 months ±60% < 1 years AOM 209 Moderate
Murray et al. (53), US CP <56 days 36 days ± 13.8 Fever 520 Low
Nelson et al. (54), US* CP 3 months−18 years 2.8 years (4.4) Pneumonia 3220 High
Nibhanipudi et al. (55), US* CP 2–17 years 5.72 years ± 0.38° (m) AOM 100 Low
7.41 years ± 0.75° (f)
Ochoa et al. (56), Spain CSr 0–18 years ±3 years (1 months−18 years) ARTI 6249 High
Ong et al. (57), US CP All ages (20% child) 33 years URTI 272 Moderate
Özkaya et al. (58), Turkey CSp 3–14 years 5.7 years ± 3.4° Influenza like illness 97 Low
4.25 years ± 2.02
Ouldali et al. (59), France qRCT <18 years 1.6 years (0.7–3.6) ARTI 196.062 High
1.7 years (0.7–3.7)
Planas et al. (60), Spain CP <3 months 35 days ± 31° Fever without source and BC (admitted) ¥ 381 Moderate
Ploin et al. (61), France CP <36 months NR Fever during influenza season 538 Moderate
Poehling et al. (62), US RCT <5 years NR Fever or ARS during influenza season 305 Moderate
Shah et al. (63), US CSr 1–18 years ± 63% 1–4 years Fever and cough or respiratory distress 3466 Moderate
Sharma et al. (64), US CSr 2–24 months 9 months ° Fever and positive influenza test 72 Low
Spiro et al. (65), US RCT 6–35 months 17.3 months° Fever or ARS 681 High
17.2 months°
Spiro et al. (66), US RCT 6 months−12 years 3.2 years AOM 283 High
3.6 years
Trautner et al. (67), US CSp <18 years 17 months (11–25 months) Hyperpyrexia 103 Moderate
de Vos-Kerkhof et al. (68), Netherlands RCT 1 months−16 years 1.7 years (0.8–3.9) Fever 439 Moderate
2.0 years (1.0–4.2)
Waddle and Jhaveri, (69), US CSr 3–36 months 17 months ± 11° FWS and BC 423 Low
15 months ± 10°
Wheeler et al. (70), US CP ≤ 18 years 3 years (1 months−20 years) Viral infections 144 Moderate

CC, case control; CP, prospective cohort; CR, retrospective cohort; CS, cross-sectional; r, retrospective; p, prospective.

*

Estimated/calculated from numbers in article.

°

Mean age is given, median age was not reported.

¥

Fever without source: as defined in corresponding study.